Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Researchers categorize patients who may benefit from lower BP targets

Since the American College of Cardiology and the American Heart Association lowered the threshold for hypertension to 130/80 millimeters of mercury in November, cardiologists have questioned the risk-benefit balance of the new guidelines.

Thumbnail

Could breastfeeding boost long-term cardiovascular health?

Women who exhibited normal blood pressure during pregnancy and breastfed children for at least six months had better cardiovascular health years later compared to women who did not breastfeed, according to new research to be presented at the American College of Cardiology’s 67th Annual Scientific Session.

Thumbnail

ACP urges less aggressive drug treatment for type 2 diabetes

The American College of Physicians (ACP) recommends a hemoglobin A1c (HbA1c) target between 7 and 8 percent for most patients with type 2 diabetes, according to a March 6 guidance statement update in the Annals of Internal Medicine.

Thumbnail

Overall costs, drug prices continue to rise for hypertension

Americans with hypertension who were enrolled in employee-sponsored health insurance plans spent 18.3 percent more on healthcare in 2016 than they did in 2012, according to an issue brief released March 6 by the Health Care Cost Institute (HCCI).

Boehringer Ingelheim and Lilly expand heart failure program for Jardiance® with new exercise capacity trials

RIDGEFIELD, Conn. and INDIANAPOLIS, March 6, 2018 /PRNewswire/ — Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced plans to expand their clinical trial program for Jardiance® in chronic heart failure with the EMPERIAL clinical trials.

Thumbnail

Routine walking cuts heart failure risk by 25% for post-menopausal women

Post-menopausal women who go on exercise walks at least twice per week enjoy a 20 to 25 percent risk reduction for heart failure, according to research that will be presented March 12 at the American College of Cardiology’s annual scientific session in Orlando, Florida.

Exercise with a pill? Drug aims to aid those with limited movement

A pill that stimulated the body to mimic the effects of exercise—including endurance and weight control—could be on the horizon for individuals who are faced with frailty, movement disorders and other diseases that inhibit their ability to exercise.

Thumbnail

Women with preeclampsia more likely to develop CVD risk factors

Women diagnosed with preeclampsia during pregnancy are significantly more likely to develop risk factors for cardiovascular disease (CVD) including high blood pressure, diabetes and high cholesterol, according to a new study to be presented at the American College of Cardiology’s 67th Annual Scientific Session.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.